ASTH - CIK 0001083446
The table below shows Astrana Health, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $114.60M | $52.20M | $68.23M | $82.13M | $70.33M | $46.16M |
| Capital expenditure | $10.11M | $8.03M | $28.53M | $22.94M | $19.22M | $1.16M |
| Investing cash flow | -$539.00M | -$192.40M | -$65.52M | -$7.11M | $16.54M | $95.49M |
| Dividends paid | - | - | - | - | - | - |
Astrana Health, Inc. reported operating cash flow of $114.60M for fiscal year 2025. That is up 119.5% from $52.20M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $21.91M (FY 2016) to $114.60M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $25.60M | $900.00K | $10.19M | $9.25M | $5.74M | $537.00K |
| Financing cash flow | $569.35M | $135.15M | $3.42M | -$20.09M | -$47.75M | -$51.70M |